RS 1060.21 - Uses authorized; regulation; penalties
A. The provisions of this Section and of the Uniform Controlled Dangerous Substances Law do not apply to anabolic steroids that are expressly intended for administration to livestock or other nonhuman species, that are approved by the federal Food and Drug Administration for such use.
B. "Anabolic steroid" as used herein means any anabolic steroid or synthetic derivative of testosterone, including but not limited to the following:
(1) Bodenone.
(2) Chlorotestosterone.
(3) Clostebol.
(4) Chorionic gonadotropin.
(5) Dehydrochlormethyltestosterone.
(6) Dihydrotestosterone.
(7) Drostanolone.
(8) Ethylestrenol.
(9) Fluoxymesterone.
(10) Mesterolone.
(11) Methandienone.
(12) Methandranone.
(13) Methandriol.
(14) Methandrostenolone.
(15) Methyltestosterone.
(16) Mibolerone.
(17) Nandrolone.
(18) Norethandrolone.
(19) Oxandrolone.
(20) Oxymesterone.
(21) Oxymetholone.
(22) Stanolone.
(23) Stanozolol.
(24) Testolactone.
(25) Testosterone.
(26) Trenbolone.
C.(1) A physician, dentist, or veterinarian shall not prescribe, dispense, deliver, or administer an anabolic steroid for human use or cause an anabolic steroid to be administered under his direction or supervision for human use except for a valid medical purpose and when required by demonstrable generally accepted medical indications. Bodybuilding, muscle enhancement, or increasing muscle bulk or strength through the use of an anabolic steroid by a person who is in good health is not a valid medical purpose.
(2) Whoever violates the provisions of this Subsection shall be subject to suspension or revocation of his license to practice medicine, dentistry, or veterinary medicine by his governing board.
(3) Whoever violates the provisions of this Subsection shall also be fined not more than five thousand dollars or imprisoned with or without hard labor for not more than five years, or both.
Acts 1988, No. 362, §1; Acts 1989, No. 345, §1; Acts 1989, No. 704, §1; Acts 1990, No. 542, §1; Acts 1991 1st E.S., No. 2, §1; Redesignated from R.S. 40:1239 by HCR 84 of 2015 R.S.